Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 4834616, 12 pages
http://dx.doi.org/10.1155/2016/4834616
Research Article

Manufacturing of Human Umbilical Cord Mesenchymal Stromal Cells on Microcarriers in a Dynamic System for Clinical Use

1Department of Anatomy and Physiology, Kansas State University, 228 Coles Hall, Manhattan, KS 66506, USA
2Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstraße 14, 35390 Gießen, Germany
3Department of Chemical Engineering, Kansas State University, 1005 Durland Hall, Manhattan, KS 66506, USA
4Faculty of Biology and Chemistry, Justus Liebig University, Ludwigstraße 23, 35390 Gießen, Germany
5Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Project Group Bioresources, Winchester Straße 2, 35392 Gießen, Germany

Received 7 October 2015; Revised 28 December 2015; Accepted 29 December 2015

Academic Editor: Renke Li

Copyright © 2016 Florian Petry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Elseberg, J. Leber, D. Salzig et al., “Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics,” International Journal of Artificial Organs, vol. 35, no. 2, pp. 93–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Schop, F. W. Janssen, L. D. S. van Rijn et al., “Growth, metabolism, and growth inhibitors of mesenchymal stem cells,” Tissue Engineering. Part A, vol. 15, no. 8, pp. 1877–1886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Prockop, “Marrow stromal cells as stem cells for nonhematopoietic tissues,” Science, vol. 276, no. 5309, pp. 71–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. A. I. Caplan and S. P. Bruder, “Mesenchymal stem cells: building blocks for molecular medicine in the 21st century,” Trends in Molecular Medicine, vol. 7, no. 6, pp. 259–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Wagner, F. Wein, A. Seckinger et al., “Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood,” Experimental Hematology, vol. 33, no. 11, pp. 1402–1416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar
  7. G. Kögler, S. Sensken, J. A. Airey et al., “A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 123–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Weiss and D. L. Troyer, “Stem cells in the umbilical cord,” Stem Cell Reviews, vol. 2, no. 2, pp. 155–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. McGuirk, J. R. Smith, C. L. Divine, M. Zuniga, and M. L. Weiss, “Wharton's Jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease,” Pharmaceuticals, vol. 8, no. 2, pp. 196–220, 2015. View at Publisher · View at Google Scholar
  10. T. Deuse, M. Stubbendorff, K. Tang-Quan et al., “Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells,” Cell Transplantation, vol. 20, no. 5, pp. 655–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. H. Yoo, I. K. Jang, M. W. Lee et al., “Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues,” Cellular Immunology, vol. 259, no. 2, pp. 150–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Najar, G. Raicevic, H. I. Boufker et al., “Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor,” Tissue Engineering Part A, vol. 16, no. 11, pp. 3537–3546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Prasanna, D. Gopalakrishnan, S. R. Shankar, and A. B. Vasandan, “Pro-inflammatory cytokines, IFNγ and TNFα, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially,” PLoS ONE, vol. 5, no. 2, article e9016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Weiss, C. Anderson, S. Medicetty et al., “Immune properties of human umbilical cord Wharton's jelly-derived cells,” STEM CELLS, vol. 26, no. 11, pp. 2865–2874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. van Poll, B. Parekkadan, I. H. Borel Rinkes, A. W. Tilles, and M. L. Yarmush, “Mesenchymal stem cell therapy for protection and repair of injured vital organs,” Cellular and Molecular Bioengineering, vol. 1, no. 1, pp. 42–50, 2008. View at Publisher · View at Google Scholar
  16. L. Wang, I. Tran, K. Seshareddy, M. L. Weiss, and M. S. Detamore, “A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering,” Tissue Engineering Part A, vol. 15, no. 8, pp. 2259–2266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Smith, K. Pfeiffer, F. Petry, N. Powell, J. Delzeit, and M. L. Weiss, “Standardizing umbilical cord mesenchymal stromal cells for translation to clinical use: selection of GMP-compliant medium and a simplified isolation method,” Stem Cells International, In press.
  18. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. E. Mitchell, M. L. Weiss, B. M. Mitchell et al., “Matrix cells from Wharton's jelly form neurons and glia,” STEM CELLS, vol. 21, no. 1, pp. 50–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. B. Lester, Stem Cells in Endocrinology, Humana Press, 2007, https://books.google.com/books?id=WExKOQe3QWAC.
  21. M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease,” Stem Cells, vol. 24, no. 3, pp. 781–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. C. Chao, K. F. Chao, Y. S. Fu, and S. H. Liu, “Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes,” PLoS ONE, vol. 3, no. 1, Article ID e1451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-C. Lin, T.-L. Ko, Y.-H. Shih et al., “Human umbilical mesenchymal stem cells promote recovery after ischemic stroke,” Stroke, vol. 42, no. 7, pp. 2045–2053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-S. Kim, T.-H. Shin, B.-C. Lee et al., “Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2,” Gastroenterology, vol. 145, no. 6, pp. 1392–1403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H.-S. Wang, S.-C. Hung, S.-T. Peng et al., “Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord,” STEM CELLS, vol. 22, no. 7, pp. 1330–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-S. Fu, Y.-C. Cheng, M.-Y. A. Lin et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism,” Stem Cells, vol. 24, no. 1, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Y.-S. Fu, Y.-T. Shih, Y.-C. Cheng, and M.-Y. Min, “Transformation of human umbilical mesenchymal cells into neurons in vitro,” Journal of Biomedical Science, vol. 11, no. 5, pp. 652–660, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. López, B. Lutjemeier, K. Seshareddy et al., “Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report,” Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 46–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. E. Bernardo, L. M. Ball, A. M. Cometa et al., “Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation,” Bone Marrow Transplantation, vol. 46, no. 2, pp. 200–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. L. M. Ball, M. E. Bernardo, H. Roelofs et al., “Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease,” British Journal of Haematology, vol. 163, no. 4, pp. 501–509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Jitschin, D. Mougiakakos, L. von Bahr et al., “Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation,” Stem Cells, vol. 31, no. 8, pp. 1715–1725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. A. K.-L. Chen, Y. K. Chew, H. Y. Tan, S. Reuveny, and S. K. W. Oh, “Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed,” Cytotherapy, vol. 17, no. 2, pp. 163–173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Dos Santos, A. Campbell, A. Fernandes-Platzgummer et al., “A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells,” Biotechnology and Bioengineering, vol. 111, no. 6, pp. 1116–1127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Cierpka, C. L. Elseberg, K. Niss, M. Kassem, D. Salzig, and P. Czermak, “hMSC production in disposable bioreactors with regards to GMP and PAT,” Chemie Ingenieur Technik, vol. 85, no. 1-2, pp. 67–75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Hupfeld, I. H. Gorr, C. Schwald et al., “Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors,” Biotechnology and Bioengineering, vol. 111, no. 11, pp. 2290–2302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Baksh, R. Yao, and R. S. Tuan, “Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow,” Stem Cells, vol. 25, no. 6, pp. 1384–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Majore, P. Moretti, F. Stahl, R. Hass, and C. Kasper, “Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 17–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. S. Ozturk and B. O. Palsson, “Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor,” Biotechnology Progress, vol. 7, no. 6, pp. 481–494, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Ljunggren and L. Häggström, “Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures,” Biotechnology and Bioengineering, vol. 44, no. 7, pp. 808–818, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. M. W. Glacken, “Catabolic control of mammalian cell culture,” Bio/Technology, vol. 6, no. 9, pp. 1041–1050, 1988. View at Publisher · View at Google Scholar · View at Scopus
  43. G. L. Tritsch and G. E. Moore, “Spontaneous decomposition of glutamine in cell culture media,” Experimental Cell Research, vol. 28, no. 2, pp. 360–364, 1962. View at Publisher · View at Google Scholar · View at Scopus
  44. M.-S. Lao and D. Toth, “Effects of ammonium and lactate on growth and metabolism of a recombinant Chinese hamster ovary cell culture,” Biotechnology Progress, vol. 13, no. 5, pp. 688–691, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. T. K. Goh, Z. Zhang, A. K. Chen et al., “Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells,” BioResearch Open Access, vol. 2, no. 2, pp. 84–97, 2013. View at Publisher · View at Google Scholar
  46. P.-C. Tseng, T.-H. Young, T.-M. Wang, H.-W. Peng, S.-M. Hou, and M.-L. Yen, “Spontaneous osteogenesis of MSCs cultured on 3D microcarriers through alteration of cytoskeletal tension,” Biomaterials, vol. 33, no. 2, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Chmiel, Bioprozesstechnik, Spektrum Akademischer, Heidelberg, Germany, 3rd edition, 2011.
  48. W. S. Hu, J. Meier, and D. I. C. Wang, “A mechanistic analysis of the inoculum requirement for the cultivation of mammalian cells on microcarriers,” Biotechnology and Bioengineering, vol. 27, no. 5, pp. 585–595, 1985. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Götherström, A. West, J. Liden, M. Uzunel, R. Lahesmaa, and K. Le Blanc, “Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells,” Haematologica, vol. 90, no. 8, pp. 1017–1026, 2005. View at Google Scholar · View at Scopus